Herbal Drug-Loaded Nanoparticles for Vitiligo Treatment: Mechanisms, Formulation Strategies, Characterization, and Therapeutic Potential
Abstract
Vitiligo is a chronic autoimmune depigmenting disorder characterized by the progressive destruction of melanocytes, resulting in the appearance of white patches on the skin. The multifactorial pathogenesis of vitiligo involves oxidative stress, autoimmune responses, inflammatory cytokines, genetic predisposition, and melanocyte apoptosis. Although conventional therapies such as phototherapy, corticosteroids, calcineurin inhibitors, and surgical interventions are available, their efficacy remains limited due to adverse effects, recurrence, prolonged treatment duration, and poor patient compliance. Herbal medicines have gained significant attention because of their antioxidant, anti-inflammatory, immunomodulatory, and melanogenesis-promoting properties. However, poor aqueous solubility, instability, low bioavailability, and inadequate skin permeation restrict their clinical application. Nanotechnology-based drug delivery systems provide an innovative platform for improving the therapeutic efficacy of herbal compounds by enhancing stability, penetration, targeted delivery, and controlled release. This review discusses the pathogenesis of vitiligo, the rationale for herbal nanoformulations, nanoparticle systems, formulation approaches, characterization parameters, biological evaluation methods, regulatory considerations, and future perspectives in vitiligo therapy.
Keywords: Vitiligo, Herbal Nanoparticles, Nanotechnology, Melanogenesis, Drug Delivery Systems, Skin Targeting, Nanomedicine.
Keywords:
Vitiligo, Nanotechnology, Melanogenesis, Drug Delivery Systems, Skin Targeting, NanomedicineDOI
https://doi.org/10.22270/jddt.v16i9.7947References
1. Vitiligo. Available from: http://www.herbsandcures.com/2007/May. Accessed July 17, 2009.
2. Vitiligo treatment. Available from: http://pushpakaran.shoutpost.com/archives/2007/May. Accessed July 17, 2009.
3. Hearing VJ. Biochemical control of melanogenesis and melanosomal organization. J Invest Dermatol Symp Proc. 1999;4(1):24-28. https://doi.org/10.1038/sj.jidsp.5640176 PMid:10537003
4. Taieb A. Intrinsic and extrinsic pathomechanisms of vitiligo. Pigment Cell Res. 2000;8:41. https://doi.org/10.1034/j.1600-0749.13.s8.9.x PMid:11041356
5. Nordlund JJ, Lerner AB. Vitiligo-it is important. Arch Dermatol. 1982;118:5-8. https://doi.org/10.1001/archderm.1982.01650130009007
6. Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CCE, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1-E13. https://doi.org/10.1111/j.1755-148X.2012.00997.x PMid:22417114 PMCid:PMC3511780
7. Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity. 2001;34:65-77. https://doi.org/10.3109/08916930108994127 PMid:11681494
8. Dwivedi M, Kemp EH, Laddha NC, Mansuri MS, Weetman AP, Begum R. Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics. Autoimmun Rev. 2015;14:49-56. https://doi.org/10.1016/j.autrev.2014.10.002 PMid:25308528
9. Boniface K, Seneschal J, Picardo M, Taieb A. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clin Rev Allergy Immunol. 2018;54:52-67. https://doi.org/10.1007/s12016-017-8622-7 PMid:28685247
10. Arora AK, Kumaran MS. Pathogenesis of vitiligo: an update. Pigment Int. 2017;4:65. https://doi.org/10.4103/2349-5847.219673
11. Garg BJ, Saraswat A, Bhatia A, Katare OP. Topical treatment in vitiligo and potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol.
12. Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo. Int J Dermatol. 1993;32:753-757. https://doi.org/10.1111/j.1365-4362.1993.tb02754.x PMid:8225724
13. Akdeniz N, Yavuz IH, Gunes Bilgili S, Ozaydin Yavuz G, Calka O. Efficacy of narrowband UVB therapies in vitiligo. J Dermatol Treat. 2014;25:196-199. https://doi.org/10.3109/09546634.2013.777381 PMid:23441902
14. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview. J Am Acad Dermatol. 2011;65:473-491. https://doi.org/10.1016/j.jaad.2010.11.061 PMid:21839315 PMCid:PMC12847362
15. Parsad D, Pandhi R, Juneja A. Effectiveness of Ginkgo biloba in vitiligo. Clin Exp Dermatol. 2003;28(3):285-287. https://doi.org/10.1046/j.1365-2230.2003.01207.x PMid:12780716
16. Asawanonda P, Klahan SO. Tetrahydrocurcuminoid cream with NB-UVB therapy in vitiligo. Photomed Laser Surg. 2010;28(5):679-684. https://doi.org/10.1089/pho.2009.2637 PMid:20961233
17. Dessai S, Bhutekar S. Formulation and evaluation of psoralen herbal cream for vitiligo. Int J Pharm Res Appl. 2023;8(2):437-444.
18. Rayabagi MH, Prajapati B. Herbal Nanoparticle-Embedded Film-Forming Spray: A Novel Topical Delivery System for Vitiligo Management. Indian J of Pharmaceutical Education and Research. 10.5530/ijper.20262653.
19. Jayaprakasam A, Darvay A, Osborne G, McGibbon D. Assessment of severity and quality of life in cutaneous disease. Clin Exp Dermatol. 2002;27:306-308. https://doi.org/10.1046/j.1365-2230.2002.01025.x PMid:12139677
20. Jowett S, Ryan T. Skin disease and handicap: impact of skin conditions. Soc Sci Med. 1985;20:425-429. https://doi.org/10.1016/0277-9536(85)90021-8 PMid:3158080
21. Jeong YM, Choi YG, Kim DS, et al. Cytoprotective effect of green tea extract and quercetin. Arch Pharm Res. 2005;28(11):1251-1256. https://doi.org/10.1007/BF02978208 PMid:16350851
22. Becatti M, Prignano F, Fiorillo C, et al. Protective effects of curcumin in vitiligo keratinocytes. Antioxid Redox Signal. 2010;13(9):1309-1321. https://doi.org/10.1089/ars.2009.2779 PMid:20085492
23. Bedi KL, Zutshi U, Chopra CL, et al. Picrorhiza kurroa, an ayurvedic herb, may potentiate photochemotherapy in vitiligo. J Ethnopharmacol. 1989;27(3):347-352. doi:10.1016/0378-8741(89)90009-3. https://doi.org/10.1016/0378-8741(89)90009-3 PMid:2615440
24. Bhatia S. Nanoparticles: types, classification, characterization, fabrication methods and drug delivery applications. Springer Sci Rev. 2016;33-93. https://doi.org/10.1007/978-3-319-41129-3_2 PMid:28298942 PMCid:PMC5334270
25. Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules for cutaneous applications. Drug Target Insights. 2007;2:117739280700200002. https://doi.org/10.1177/117739280700200002
26. Wadher KJ, Kakde RB, Umekar MJ. Formulation and evaluation of sustained release tablets of metformin hydrochloride using hydrophilic and hydrophobic polymers. Indian J Pharm Sci. 2011;73(2):208-215. https://doi.org/10.4103/0250-474X.91579 PMid:22303065 PMCid:PMC3267306
27. Cho E, Cho W, Cha KH, Park J, Kim MS, Kim JS, et al. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation using hydrophilic additives. Int J Pharm. 2010;396:91-98. https://doi.org/10.1016/j.ijpharm.2010.06.016 PMid:20558265
28. Moin A, Deb TK, Osmani RA, Bhosale RR, Hani U. Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy. J Basic Clin Pharm. 2016;7:39. https://doi.org/10.4103/0976-0105.177705 PMid:27057125 PMCid:PMC4804404
29. Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing dissolution of poorly soluble drugs. Int J Pharm. 2006;312(1-2):179-186. https://doi.org/10.1016/j.ijpharm.2006.01.008 PMid:16469459
30. Detroja C, Chavhan S, Sawant K. Enhanced antihypertensive activity of candesartan cilexetil nanosuspension. Sci Pharm. 2011;79(3):635-652. https://doi.org/10.3797/scipharm.1103-17 PMid:21886909 PMCid:PMC3163369
31. Li W, Yang Y, Tian Y, Xu X, Chen Y, Mu L, et al. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension. Int J Pharm. 2011;408(1 2):157-162. https://doi.org/10.1016/j.ijpharm.2011.01.059 PMid:21295124
32. Londhe VY, Umalkar KB. Formulation development and evaluation of fast dissolving film of telmisartan. Indian J Pharm Sci. 2012;74(2):122-6. https://doi.org/10.4103/0250-474X.103842
33. Pandya VM, Patel JK. Formulation and optimization of nanosuspensions for enhancing simvastatin dissolution. Dissolut Technol. 2011;18(3):40-45. https://doi.org/10.14227/DT180311P40
34. Mandal B, Alexander KS, Riga AT. Sulfacetamide-loaded Eudragit RL100 nanosuspension for ocular delivery. J Pharm Pharm Sci. 2010;13(4):510-523. https://doi.org/10.18433/J3SW2T PMid:21486528
35. Grodowska K, Parczewski A. Analytical methods for residual solvents determination in pharmaceutical products. Acta Pol Pharm. 2010;67(1):13-26.
36. Zhu YP, Wang SQ, Xu AE. A mouse model of vitiligo induced by monobenzone. Exp Dermatol. 2013;22:499-501. https://doi.org/10.1111/exd.12184 PMid:23800067
37. Jyothi VGSS, Pawar J, Fernandes V, et al. Film forming topical dermal spray of meloxicam attenuated pain and inflammation in carrageenan-induced paw oedema in Sprague Dawley rats. J Drug Deliv Sci Technol. 2022;70:103195. https://doi.org/10.1016/j.jddst.2022.103195
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Madhuri H Rayabagi , Bijal Prajapati , H M Madhukumar , Girish Bolakatti
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.